The Stem Cell Hope

A landmark book by the senior science writer at Time magazine introduces us to a medical breakthrough that can save our lives. Few people know much about stem cell research beyond the ethical questions raised by using embryos. But in the last decade, stem cell research has made huge advances toward eliminating some of our most intractable diseases. Now this sweeping and accessible book introduces us to this cutting-edge science that will revolutionize medicine and change the way we think about and treat disease. Alice Park takes us from stem cell's controversial beginnings to the recent electrifying promise of being able to create the versatile cells without using embryos at all. She shows us how stem cells give researchers an unprecedented ability to study disease while giving patients the promise of replacing diseased cells with healthy new ones. And she profiles the scientists and leaders-many with their own compelling stories-who have fueled the quest and will continue to shape the field in years to come.

Stem Cell Research takes a multi-disciplinary approach to the topic of human embryonic stem cell research, starting with the breakthrough discovery up through the present day controversy. The book invites the reader to join the conversation by providing a well balanced approach to many of the issues surrounding the development of this controversial scientific field. It includes the thoughts and experiences of scientists, journalists and ethicists as it tried to approach the topic through a variety of different academic disciplines. The book will help the non-scientist understand the biology, research regulations and funding; and simultaneously it will help the scientist better comprehend the full spectrum of ethical, religious, and policy debates.

During the last two decades, stem cells have progressed from merely a concept to a vibrant field of regenerative medicine which is aimed at addressing the root cause of the problem rather than conventional methods of intervention that mostly provide symptomatic relief.Stem cell therapy either alone or in combination with the other established treatment strategies is a hope for patients who suffer from the 'incurable' diseases such as Alzheimer, diabetes, myocardial infarction etc. Besides aspirations in the clinical perspective, stem cells provide excellent in vitro disease models for drug development.Given the significance of the field, the proposed book will be a compilation of the bench experience of experts from various research labs involved in the cutting edge area of stem cell research.

This book is a compilation of the bench experience of leading experts from various research labs involved in the cutting edge area of research. The authors describe the use of stem cells both as part of the combinatorial therapeutic intervention approach and as tools (disease model) during drug development, highlighting the shift from a conventional symptomatic treatment strategy to addressing the root cause of the disease process. The book is a continuum of the previously published book entitled "Stem Cells: from Drug to Drug Discovery" which was published in 2017.

An up-to-date guide on the stem cell controversy and the discovery, hope, and fear that surrounds it.

After more than four decades living with multiple sclerosis, New York Times bestselling author Richard M. Cohen finds a flicker of hope in a groundbreaking medical procedure. Richard Cohen struggles with failing limbs and is legally blind. He has survived two bouts of colon cancer and a life-threatening blood clot in his lungs. After enduring decades of harsh treatments and invasive therapies, Cohen decided to trade in his life as a patient. In 2012, Cohen and his wife, Meredith Vieira, were invited to host and chair an adult stem cell conference at the Vatican. Scientists would be gathering in Rome to discuss stem cell therapy for autoimmune diseases, including MS. A believer in the power of denial and determination over faith and hope, Cohen was caught off guard by what he learned. Medical technology had advanced further and more quickly than Cohen had known. Could there be a chance his health could improve? Could MS be cured? As Cohen took part in a pioneering stem cell protocol, he opened himself to the possibility of hope for the first time in his adult life. Cohen's deep dive into the cutting-edge world of stem cell research and his journalistic investigation of hope includes interviews with doctors, scientists, and religious leaders, as well as conversations with others living with chronic conditions, all with the goal of understanding a hope that is both elusive and alluring. As drily funny as it is emotionally vulnerable, Chasing Hope navigates the fascinating and ever-changing intersection between illness and hope.

Traces findings in biomedical research about the potential for stem cells to enable revolutionary cures, offering insight into the controversy surrounding stem-cell research and its related international biological arms race.

Recent scientific breakthroughs, celebrity patient advocates, and conflicting religious beliefs have come together to bring the state of stem cell researchâ€"specifically embryonic stem cell researchâ€"into the political crosshairs. President Bush's watershed policy statement allows federal funding for embryonic stem cell research but only on a limited number of stem cell lines. Millions of Americans could be affected by the continuing political debate among policymakers and the public. Stem Cells and the Future of Regenerative Medicine provides a deeper exploration of the biological, ethical, and funding questions prompted by the therapeutic potential of undifferentiated human cells. In terms accessible to lay readers, the book summarizes what we know about adult and embryonic stem cells and discusses how to go about the transition from mouse studies to research that has therapeutic implications for people. Perhaps most important, Stem Cells and the Future of Regenerative Medicine also provides an overview of the moral and ethical problems that arise from the use of embryonic stem cells. This timely book compares the impact of public and private research funding and discusses approaches to appropriate research oversight. Based on the insights of leading scientists, ethicists, and other authorities, the book offers authoritative recommendations regarding the use of existing stem cell lines versus new lines in research, the important role of the federal government in this field of research, and other fundamental issues.